Apelin-13 deteriorates hypertension in rats after damage of the vascular endothelium by ADMA

Endothelial dysfunction and cardiovascular disease in early-stage chronic kidney disease: Cause or association?

(2012) William E. Moody et al.   ATHEROSCLEROSIS

Elevation of serum apelin-13 is positively correlated with ADMA in patients on maintenance hemodialysis

(2011) D.-L. Zhang et al.   CLINICAL NEPHROLOGY

Apelin-13 passes through the ADMA-damaged endothelial barrier and acts on vascular smooth muscle cells

(2011) Li-Yan Wang et al.   PEPTIDES

Modulation of the apelin/APJ system in heart failure and atherosclerosis in man

(2010) Sarah L Pitkin et al.   BRITISH JOURNAL OF PHARMACOLOGY

[Pyr 1 ]Apelin-13 Identified as the Predominant Apelin Isoform in the Human Heart

(2009) Janet J. Maguire et al.   HYPERTENSION

Asymmetrical dimethylarginine is associated with renal and cardiovascular outcomes and all-cause mortality in renal transplant recipients

(2009) Sadollah Abedini et al.   KIDNEY INTERNATIONAL

Asymmetric Dimethylarginine and Lipid Peroxidation Products in Early Autosomal Dominant Polycystic Kidney Disease

(2008) Dan Wang et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Redox Control of Endothelial Function and Dysfunction: Molecular Mechanisms and Therapeutic Opportunities

(2008) Shane R. Thomas et al.   ANTIOXIDANTS & REDOX SIGNALING

Roles of Oxidants, Nitric Oxide, and Asymmetric Dimethylarginine in Endothelial Function

(2008) Rüdiger Siekmeier et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS

Effect of apelin on glomerular hemodynamic function in the rat kidney

(2008) Annette Hus-Citharel et al.   KIDNEY INTERNATIONAL